| ARR | Absolute risk reduction |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| NNV | Number needed to vaccinate |
| RR | Risk ratio |
| RoB 2 | Revised Cochrane Risk of Bias tool |
| CI | Confidence interval |
| CYD-TDV | Chimeric yellow fever dengue–tetravalent dengue vaccine |
| DENV | Dengue virus |
| DENV-1 | Dengue virus serotype 1 |
| DENV-2 | Dengue virus serotype 2 |
| DENV-3 | Dengue virus serotype 3 |
| DENV-4 | Dengue virus serotype 4 |
| GMR | Geometric mean ratio |
| GMT | Geometric mean titre |
| I2 | Inconsistency statistic |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROSPERO | International Prospective Register of Systematic Reviews |
| TAK-003 | Tetravalent dengue vaccine candidate |
| VCD | Virologically confirmed dengue |